Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Team Gr.: Embracing Diversity to Achieve Precision/Health Equity -Gen. Omics-LOI

University of Ottawa

$20,000.00

Enabling precision interventions for individuals with IBD

FY 2023-24

Summary
Inflammatory Bowel Disease (IBD) affects millions of people worldwide. Canada has one of the highest IBD rates in the world, and living in Canada has proven to be a risk factor for immigrants from low incidence IBD countries. While early effective treatment is key to managing IBD, current therapies are increasingly expensive, do not provide relief for all and do not address IBD's underlying causes. Patients frequently experience relapses, leading to variable outcomes and a lack of sustained improvement. This leaves patients with costly out-of-pocket expenses, compromised quality of life, persistent symptoms, and at high risk for further complications. Developing more effective treatments is imperative to address both these medical needs and economic realities. We have shown that the gut microbiome plays a significant role in IBD pathogenesis and have developed a precision fiber intervention approach to manipulate the gut microbiome in IBD patients by restoring a healthy microbiome. While our preliminary results are promising, most participants in our studies were Caucasians of European descent. Thus, we are hampered by an incomplete understanding of exactly how each person's gut microbiome interacts with fibers and whether these interactions are similar between different peoples. With this project, we will gain a better understanding of the specific characteristics within each patient's microbiome that determine the success or failure of these fibers and determine whether these characteristics align with those found in individuals with IBD from non-European backgrounds. This will allow us to improve our approach and ensure that our precision nutritional intervention is matching the right patient with the right fiber at the right time. This new treatment paradigm will significantly change the therapeutic management of IBD by targeting the root causes of IBD; providing long-lasting remission with minimal side effects and increased overall quality of life.
Program
Team Gr.: Embracing Diversity to Achieve Precision/Health Equity -Gen. Omics-LOI
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
500688
Name
Stintzi Alain
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Team Grant: Embracing Diversity to Achieve Precision & Health Equity
Projecttitle
Enabling precision interventions for individuals with IBD
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$20,000
Cihrequipment2
$0
Programname2
Team Gr.: Embracing Diversity to Achieve Precision/Health Equity -Gen. Omics-LOI
Keyworddelim
Cazyme; Ibd; Microbiome; Omics
Abstract
Inflammatory Bowel Disease (IBD) affects millions of people worldwide. Canada has one of the highest IBD rates in the world, and living in Canada has proven to be a risk factor for immigrants from low incidence IBD countries. While early effective treatment is key to managing IBD, current therapies are increasingly expensive, do not provide relief for all and do not address IBD's underlying causes. Patients frequently experience relapses, leading to variable outcomes and a lack of sustained improvement. This leaves patients with costly out-of-pocket expenses, compromised quality of life, persistent symptoms, and at high risk for further complications. Developing more effective treatments is imperative to address both these medical needs and economic realities. We have shown that the gut microbiome plays a significant role in IBD pathogenesis and have developed a precision fiber intervention approach to manipulate the gut microbiome in IBD patients by restoring a healthy microbiome. While our preliminary results are promising, most participants in our studies were Caucasians of European descent. Thus, we are hampered by an incomplete understanding of exactly how each person's gut microbiome interacts with fibers and whether these interactions are similar between different peoples. With this project, we will gain a better understanding of the specific characteristics within each patient's microbiome that determine the success or failure of these fibers and determine whether these characteristics align with those found in individuals with IBD from non-European backgrounds. This will allow us to improve our approach and ensure that our precision nutritional intervention is matching the right patient with the right fiber at the right time. This new treatment paradigm will significantly change the therapeutic management of IBD by targeting the root causes of IBD; providing long-lasting remission with minimal side effects and increased overall quality of life.
Competitiondate
202402
Approvedterm2
1 yr 0 mth
Pinamesdelim
Stintzi, Alain; Couture, Jean-François; Figeys, Daniel; Mack, David R; Roussel, Charlène R
Approvedterm
1 an 0 mois
Cihrcontribution2
III~ $20,000~ $0~